117 related articles for article (PubMed ID: 33632114)
1. Exploration of SQC Formula Effect on Type 2 Diabetes Mellitus by Whole Transcriptome Profile in Rats.
Fu X; Zhou X; Liu Y; Lei Y; Xie H; Leng Y; Gao H; Xie C
Endocr Metab Immune Disord Drug Targets; 2021; 21(7):1261-1269. PubMed ID: 33632114
[TBL] [Abstract][Full Text] [Related]
2. Exploration of the Effect and Mechanism of ShenQi Compound in a Spontaneous Diabetic Rat Model.
Liu Y; Kang J; Gao H; Zhang X; Chao J; Gong G; Yuan H; Xie C
Endocr Metab Immune Disord Drug Targets; 2019; 19(5):622-631. PubMed ID: 30799801
[TBL] [Abstract][Full Text] [Related]
3. Exploring the Protective Effect of ShenQi Compound on Skeletal Muscle in Diabetic Macrovasculopathy Mice.
Duan Y; Gao H; Su H; Liu A; Liu Y; Yuan H; Xie C
Endocr Metab Immune Disord Drug Targets; 2020; 20(6):943-951. PubMed ID: 32096754
[TBL] [Abstract][Full Text] [Related]
4. Preliminary Study of the Distinctive Mechanism of Shenqi Compound in Treating Rats with Type 2 Diabetes Mellitus by Comparing with Metformin.
Fu X; Zhou X; Liu Y; Lei Y; Xie H; Leng Y; Gao H; Xie C
Curr Vasc Pharmacol; 2023; 21(2):120-127. PubMed ID: 36752289
[TBL] [Abstract][Full Text] [Related]
5. The effect of Liuwei Dihuang decoction on PI3K/Akt signaling pathway in liver of type 2 diabetes mellitus (T2DM) rats with insulin resistance.
Dai B; Wu Q; Zeng C; Zhang J; Cao L; Xiao Z; Yang M
J Ethnopharmacol; 2016 Nov; 192():382-389. PubMed ID: 27401286
[TBL] [Abstract][Full Text] [Related]
6. Molecular mechanism of Fufang Zhenzhu Tiaozhi capsule in the treatment of type 2 diabetes mellitus with nonalcoholic fatty liver disease based on network pharmacology and validation in minipigs.
Wang H; Tan H; Zhan W; Song L; Zhang D; Chen X; Lin Z; Wang W; Yang Y; Wang L; Bei W; Guo J
J Ethnopharmacol; 2021 Jun; 274():114056. PubMed ID: 33771638
[TBL] [Abstract][Full Text] [Related]
7. Shenqi compound ameliorates type-2 diabetes mellitus by modulating the gut microbiota and metabolites.
Zhang X; Wang H; Xie C; Hu Z; Zhang Y; Peng S; He Y; Kang J; Gao H; Yuan H; Liu Y; Fan G
J Chromatogr B Analyt Technol Biomed Life Sci; 2022 Apr; 1194():123189. PubMed ID: 35219959
[TBL] [Abstract][Full Text] [Related]
8. Antidiabetic effect of total flavonoids from Sanguis draxonis in type 2 diabetic rats.
Chen F; Xiong H; Wang J; Ding X; Shu G; Mei Z
J Ethnopharmacol; 2013 Oct; 149(3):729-36. PubMed ID: 23933499
[TBL] [Abstract][Full Text] [Related]
9. The protective role of shenqi compound in type 2 diabetes: A comprehensive investigation of pancreatic β-cell function and mass.
Yang C; Liu H; Xie Z; Yang Q; Du L; Xie C
Biomed Pharmacother; 2023 Oct; 166():115287. PubMed ID: 37572639
[TBL] [Abstract][Full Text] [Related]
10. Tangganjian decoction ameliorates type 2 diabetes mellitus and nonalcoholic fatty liver disease in rats by activating the IRS/PI3K/AKT signaling pathway.
Fan Y; He Z; Wang W; Li J; Hu A; Li L; Yan L; Li Z; Yin Q
Biomed Pharmacother; 2018 Oct; 106():733-737. PubMed ID: 29990865
[TBL] [Abstract][Full Text] [Related]
11. Improving hepatic mitochondrial biogenesis as a postulated mechanism for the antidiabetic effect of Spirulina platensis in comparison with metformin.
Oriquat GA; Ali MA; Mahmoud SA; Eid RMHM; Hassan R; Kamel MA
Appl Physiol Nutr Metab; 2019 Apr; 44(4):357-364. PubMed ID: 30208279
[TBL] [Abstract][Full Text] [Related]
12. Metformin regulates atrial SK2 and SK3 expression through inhibiting the PKC/ERK signaling pathway in type 2 diabetic rats.
Liu CH; Hua N; Fu X; Pan YL; Li B; Li XD
BMC Cardiovasc Disord; 2018 Dec; 18(1):236. PubMed ID: 30545309
[TBL] [Abstract][Full Text] [Related]
13. Assessment of Pharmacological Responses to an Anti-diabetic Drug in a New Obese Type 2 Diabetic Rat Model.
Murai Y; Ohta T; Tadaki H; Miyajima K; Shinohara M; Fatchiyah F; Yamada T
Med Arch; 2017 Dec; 71(6):380-384. PubMed ID: 29416195
[TBL] [Abstract][Full Text] [Related]
14. [Effects of shenqi compound on the mRNA expression of AT1R in the aorta of GK rats].
Zhuang C; Xie CG; Chen M; Liu Y; Gao H
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2013 Mar; 33(3):351-5. PubMed ID: 23713249
[TBL] [Abstract][Full Text] [Related]
15. [Meilian Xiaoke capsule combined with metformin for protecting islet cells and lowering blood glucose in diabetic rats].
Hu C; Zhang S; Jin X; Tong L
Nan Fang Yi Ke Da Xue Xue Bao; 2014 Aug; 34(9):1365-9. PubMed ID: 25263377
[TBL] [Abstract][Full Text] [Related]
16. Network pharmacology and metabolomics study on the intervention of traditional Chinese medicine Huanglian Decoction in rats with type 2 diabetes mellitus.
Pan L; Li Z; Wang Y; Zhang B; Liu G; Liu J
J Ethnopharmacol; 2020 Aug; 258():112842. PubMed ID: 32333952
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of hypoglycemic efficacy of tangningtongluo formula, a traditional Chinese Miao medicine, in two rodent animal models.
Cheng L; Meng XB; Lu S; Wang TT; Liu Y; Sun GB; Sun XB
J Diabetes Res; 2014; 2014():745419. PubMed ID: 25431772
[TBL] [Abstract][Full Text] [Related]
18. Sanbai Melon Seed Oil Exerts Its Protective Effects in a Diabetes Mellitus Model via the Akt/GSK-3
Wang F; Xi Y; Liu W; Li J; Zhang Y; Jia M; He Q; Zhao H; Wang S
J Diabetes Res; 2019; 2019():5734723. PubMed ID: 31612149
[TBL] [Abstract][Full Text] [Related]
19. Scutellaria baicalensis enhances the anti-diabetic activity of metformin in streptozotocin-induced diabetic Wistar rats.
Waisundara VY; Hsu A; Huang D; Tan BK
Am J Chin Med; 2008; 36(3):517-40. PubMed ID: 18543386
[TBL] [Abstract][Full Text] [Related]
20. Alterations in pancreatic protein expression in STZ-induced diabetic rats and genetically diabetic mice in response to treatment with hypoglycemic dipeptide Cyclo (His-Pro).
Park SW; Choi SA; Yun JW; Choi JW
Cell Physiol Biochem; 2012; 29(3-4):603-16. PubMed ID: 22616141
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
